Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease.

Mazari FA, Khan JA, Carradice D, Samuel N, Gohil R, McCollum PT, Chetter IC.

Br J Surg. 2013 Aug;100(9):1172-9. doi: 10.1002/bjs.9200.

PMID:
23842831
2.

Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease.

Mazari FA, Khan JA, Carradice D, Samuel N, Abdul Rahman MN, Gulati S, Lee HL, Mehta TA, McCollum PT, Chetter IC.

Br J Surg. 2012 Jan;99(1):39-48. doi: 10.1002/bjs.7710. Epub 2011 Oct 21.

PMID:
22021102
3.

Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication.

Mazari FA, Gulati S, Rahman MN, Lee HL, Mehta TA, McCollum PT, Chetter IC.

Ann Vasc Surg. 2010 Jan;24(1):69-79. doi: 10.1016/j.avsg.2009.07.005. Epub 2009 Sep 17.

PMID:
19762206
4.

Long-term outcomes of a randomized clinical trial of supervised exercise, percutaneous transluminal angioplasty or combined treatment for patients with intermittent claudication due to femoropopliteal disease.

Mazari FA, Khan JA, Samuel N, Smith G, Carradice D, McCollum PC, Chetter IC.

Br J Surg. 2017 Jan;104(1):76-83. doi: 10.1002/bjs.10324. Epub 2016 Oct 20.

PMID:
27763685
5.

Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial.

Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG.

J Vasc Surg. 2008 Dec;48(6):1472-80. doi: 10.1016/j.jvs.2008.06.016. Epub 2008 Sep 4.

6.

Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy.

de Vries SO, Visser K, de Vries JA, Wong JB, Donaldson MC, Hunink MG.

Radiology. 2002 Jan;222(1):25-36.

PMID:
11756701
7.

A non-randomised controlled trial of the clinical and cost effectiveness of a Supervised Exercise Programme for claudication.

Lee HL, Mehta T, Ray B, Heng MS, McCollum PT, Chetter IC.

Eur J Vasc Endovasc Surg. 2007 Feb;33(2):202-7. Epub 2006 Dec 4.

8.

An analysis of relationship between quality of life indices and clinical improvement following intervention in patients with intermittent claudication due to femoropopliteal disease.

Mazari FA, Carradice D, Rahman MN, Khan JA, Mockford K, Mehta T, McCollum PT, Chetter IC.

J Vasc Surg. 2010 Jul;52(1):77-84. doi: 10.1016/j.jvs.2010.01.085. Epub 2010 May 14.

10.

Systematic review of exercise training or percutaneous transluminal angioplasty for intermittent claudication.

Frans FA, Bipat S, Reekers JA, Legemate DA, Koelemay MJ.

Br J Surg. 2012 Jan;99(1):16-28. doi: 10.1002/bjs.7656. Epub 2011 Sep 16. Review.

PMID:
21928409
11.
12.

Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft.

Sachs T, Pomposelli F, Hamdan A, Wyers M, Schermerhorn M.

J Vasc Surg. 2011 Oct;54(4):1021-1031.e1. doi: 10.1016/j.jvs.2011.03.281. Epub 2011 Aug 31.

13.

The cost-effectiveness of supervised exercise for the treatment of intermittent claudication.

Bermingham SL, Sparrow K, Mullis R, Fox M, Shearman C, Bradbury A, Michaels J.

Eur J Vasc Endovasc Surg. 2013 Dec;46(6):707-14. doi: 10.1016/j.ejvs.2013.09.005. Epub 2013 Sep 12. Review.

14.

Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial.

Whyman MR, Fowkes FG, Kerracher EM, Gillespie IN, Lee AJ, Housley E, Ruckley CV.

J Vasc Surg. 1997 Oct;26(4):551-7.

15.

Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease.

Treesak C, Kasemsup V, Treat-Jacobson D, Nyman JA, Hirsch AT.

Vasc Med. 2004 Nov;9(4):279-85.

PMID:
15678620
16.

SUPERvised exercise therapy or immediate PTA for intermittent claudication in patients with an iliac artery obstruction--a multicentre randomised controlled trial; SUPER study design and rationale.

Frans FA, Bipat S, Reekers JA, Legemate DA, Koelemay MJ; SUPER Study Collaborators.

Eur J Vasc Endovasc Surg. 2012 Apr;43(4):466-71. doi: 10.1016/j.ejvs.2012.01.014. Epub 2012 Feb 10.

17.

Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial.

Reynolds MR, Apruzzese P, Galper BZ, Murphy TP, Hirsch AT, Cutlip DE, Mohler ER 3rd, Regensteiner JG, Cohen DJ.

J Am Heart Assoc. 2014 Nov 11;3(6):e001233. doi: 10.1161/JAHA.114.001233.

18.

Cost-effectiveness of exercise therapy in patients with intermittent claudication: supervised exercise therapy versus a 'go home and walk' advice.

van Asselt AD, Nicolaï SP, Joore MA, Prins MH, Teijink JA; Exercise Therapy in Peripheral Arterial Disease Study Group.

Eur J Vasc Endovasc Surg. 2011 Jan;41(1):97-103. doi: 10.1016/j.ejvs.2010.06.024. Epub 2010 Dec 14.

19.

Endovascular intervention for treatment of claudication: is it cost-effective?

O'Brien-Irr MS, Harris LM, Dosluoglu HH, Dryjski ML.

Ann Vasc Surg. 2010 Aug;24(6):833-40. doi: 10.1016/j.avsg.2010.03.025.

PMID:
20638623
20.

Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial.

Saxon RR, Coffman JM, Gooding JM, Natuzzi E, Ponec DJ.

J Vasc Interv Radiol. 2003 Mar;14(3):303-11.

PMID:
12631634

Supplemental Content

Support Center